These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1465058)

  • 1. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
    Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
    Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein abnormalities in chronic haemodialysis patients.
    Parsy D; Dracon M; Cachera C; Parra HJ; Vanhoutte G; Tacquet A; Fruchart JC
    Nephrol Dial Transplant; 1988; 3(1):51-6. PubMed ID: 3132640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anomalies of lipoprotein metabolism in chronic renal insufficiency].
    Lacour B; Massy ZA; Jungers P; Drueke T
    Nephrologie; 1993; 14(2):75-90. PubMed ID: 8327031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in factors that alter lipid metabolism in chronic renal failure.
    Drüeke T; Lacour B; Roullet JB; Funck-Brentano JL
    Kidney Int Suppl; 1983 Dec; 16():S134-8. PubMed ID: 6588243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis].
    Scarazatti E; Garavaglia G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):15-21. PubMed ID: 3977994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
    Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
    Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
    Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM
    Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
    Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
    Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.